» Articles » PMID: 36071287

Exploring the Inverse Association of Glioblastoma Multiforme and Alzheimer's Disease Via Bioinformatics Analysis

Overview
Journal Med Oncol
Publisher Springer
Specialty Oncology
Date 2022 Sep 7
PMID 36071287
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma multiforme (GBM) and Alzheimer's disease (AD) are two major diseases in the nervous system with a similar peak age of onset, which has the typical characteristics of high cost, difficult treatment, and poor prognosis. Epidemiological studies and a few molecular biological studies have hinted at an opposite relationship between AD and GBM. However, there are few studies on their reverse relationship, and the regulatory mechanism is still unclear, indicating that further systematic research is urgently needed. Our study firstly employs advanced bioinformatics methods to explore the inverse relationship between them and find various target drugs. We obtained the gene expression dataset from public databases (GEO, TCGA, and GTEx). Then, we identified 122 differentially expressed genes (DEGs) of AD and GBM. Four significant gene modules were identified through protein-protein interaction (PPI) and module construction, and 13 hub genes were found using cytoHubba. We constructed co-expression networks and found various target drugs through these hub genes. Functional enrichment analysis revealed that the AMPK pathway, cell cycle, and cellular senescence play important roles in AD and GBM. Our study may provide a potential direction for studying the opposite molecular mechanism of AD and GBM in the future.

Citing Articles

A bird's eye view to the homeostatic, Alzheimer and Glioblastoma attractors.

Nieves J, Gil G, Gonzalez A Heliyon. 2025; 11(4):e42445.

PMID: 40028606 PMC: 11867265. DOI: 10.1016/j.heliyon.2025.e42445.


Deciphering novel mitochondrial signatures: multi-omics analysis uncovers cross-disease markers and oligodendrocyte pathways in Alzheimer's disease and glioblastoma.

Xu X, Wang J, Chen T, Wang S, Wang F, He J Front Aging Neurosci. 2025; 17:1536142.

PMID: 40018519 PMC: 11865232. DOI: 10.3389/fnagi.2025.1536142.


Pericytes Are Immunoregulatory Cells in Glioma Genesis and Progression.

Martinez-Morga M, Garrigos D, Rodriguez-Montero E, Pombero A, Garcia-Lopez R, Martinez S Int J Mol Sci. 2024; 25(10).

PMID: 38791110 PMC: 11120873. DOI: 10.3390/ijms25105072.


A review and analysis of key biomarkers in Alzheimer's disease.

Zhang Z, Liu X, Zhang S, Song Z, Lu K, Yang W Front Neurosci. 2024; 18:1358998.

PMID: 38445255 PMC: 10912539. DOI: 10.3389/fnins.2024.1358998.


Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer's Disease.

Shi J, Huang S Int J Mol Sci. 2024; 25(1).

PMID: 38203185 PMC: 10778632. DOI: 10.3390/ijms25010016.

References
1.
Carlsson S, Brothers S, Wahlestedt C . Emerging treatment strategies for glioblastoma multiforme. EMBO Mol Med. 2014; 6(11):1359-70. PMC: 4237465. DOI: 10.15252/emmm.201302627. View

2.
Qiu C, Kivipelto M, von Strauss E . Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009; 11(2):111-28. PMC: 3181909. View

3.
Thakkar J, Dolecek T, Horbinski C, Ostrom Q, Lightner D, Barnholtz-Sloan J . Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):1985-96. PMC: 4185005. DOI: 10.1158/1055-9965.EPI-14-0275. View

4.
Driver J . Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence. Biogerontology. 2014; 15(6):547-57. DOI: 10.1007/s10522-014-9523-2. View

5.
Roe C, Behrens M, Xiong C, Miller J, Morris J . Alzheimer disease and cancer. Neurology. 2005; 64(5):895-8. DOI: 10.1212/01.WNL.0000152889.94785.51. View